Question · asked by 1 review

Community‐based buprenorphine vs placebo: Drug use

It is very uncertain whether community‐based buprenorphine changes end of treatment drug use compared with placebo (very low certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Community‐based buprenorphine vs placebo
End of treatment drug use · females offenders
It is very uncertain whether community‐based buprenorphine changes end of treatment drug use compared with placebo (very low certainty).
Interventions for female drug‐using offenders (2019) · Cochrane Headline outcomes only
RR 0.57 [0.27, 1.2]1 study · 36 participantsVery low
Community‐based buprenorphine vs placebo
Drug use at 3 months · females offenders
It is very uncertain whether community‐based buprenorphine changes drug use at 3 months compared with placebo (very low certainty).
Interventions for female drug‐using offenders (2019) · Cochrane Headline outcomes only
RR 0.58 [0.25, 1.35]1 study · 36 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Interventions for female drug‐using offenders
2019 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.